July 23rd, 2021
View it online if you can’t see pictures
Just published: New ESMO-EURACAN-GENTURIS Guidelines for soft tissue sarcomas
The updated ESMO-EURACAN-GENTURIS (European Society for Medical Oncology; European Reference Network for…
Read ArticleJuly 22nd, 2021
ABOUT | NEWS | EVENTS | CONTACT | DONATE
Genetic Counseling for Rare and Undiagnosed Conditions: What Is it, Do I Need It and How Can I Find It?
Date:
Thursday, August 12, 2021
Time:
2:00 – 2:45pm ET
Register Now
Many rare diseases have…
Read ArticleJuly 17th, 2021
Chondrosarcoma CS Foundation, Inc.
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue (VIA Zoom)
Tuesday, September 14, 2021
7:30PM – 9:00PM (Eastern Standard Time / New York)
The Chondrosarcoma CS Foundation,…
Read ArticleJuly 15th, 2021
Taking Charge of Your Care
Virtual Dialogue 3
September 14, 7:30PM -9:00PM EST Via Zoom
Registration: https://csfshayna.org/virtual-dialogue3-registration/
Chondrosarcoma Survivors and Sarcoma Providers will discuss how you can make informed…
Read Article …
Read ArticleJuly 12th, 2021
Chondrosarcoma CS Foundation, Inc.
Virtual Dialogue 3: Taking Charge of Your Care
Third International Virtual Dialogue (VIA Zoom)
Tuesday, September 14, 2021
7:30PM –…
July 5th, 2021
This #SarcomaAwareness Month, please help raise awareness of the symptoms of bone sarcoma by liking and sharing our graphic below.
Symptoms of bone sarcoma / primary bone cancer can be very general and often appear similar to the symptoms of sports…
Read ArticleJuly 2nd, 2021
Listed below is a message sent by my late daughter Shayna two years ago (July 2, 2019) to promote Sarcoma Awareness Month.
Yesterday was the first day of Sarcoma Awareness Month. As someone that is currently fighting a sarcoma I can say that my…
Read ArticleJune 27th, 2021
Published: Jun 21, 2021
SAN DIEGO, June 21, 2021 /PRNewswire/ — InhibRx, Inc. (Nasdaq: INBX), a biotechnology company with four clinical programs in development, announced initiation of a potential registration-enabling Phase 2 study of INBRX-109…
Read ArticleJune 19th, 2021
SUMMARY
This phase II trial studies the effect of belinostat and SGI-110 (guadecitabine) combination therapy in treating patients with conventional chondrosarcoma that cannot be removed by surgery (unresectable) and has spread to other places in…
Read Article